Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Other adjustments

Other segment segments

Oncology & Multispecialty
-$23M
Prescription Technology Solutions
-$1M
North American Pharmaceutical
$0

Similar metrics at other companies

Installed Building Products logo
IBPOther — Other adjustments
$0
Installed Building Products logo
IBPInstallation — Other adjustments
$300K-50.0%
ABM Industries logo
ABMTechnical Solutions — Adjustments
-$800K
Mirion Technologies logo
MIRMedical Segment — Measurement period adjustment
$0
Belden logo
BDCAutomation Solutions — Acquisition adjustments
-$80K
Avery Dennison logo
AVYSolutions Group — Acquisition adjustments
$0

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.7B+16.8%
Enterprise value$110.42B+14.5%
P/E22.4×-5.4×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)North American PharmaceuticalOncology & MultispecialtyPrescription Technology SolutionsMedical-Surgical SolutionsTotal
Balance, March 31, 2026$2,781$3,963$2,065$2,507$11,316
Goodwill acquired1313
Disposals(2)(2)
Foreign currency translation adjustments, net(26)(26)
Other adjustments (1)(23)(23)
Balance, June 30, 2026$2,755$3,951$2,065$2,507$11,278

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's medical-surgical solutions — other adjustments?
McKesson (MCK) reported medical-surgical solutions — other adjustments of $0 in Q2 2026.
What does medical-surgical solutions — other adjustments mean?
Includes miscellaneous non-recurring or non-operational items specific to the Medical-Surgical Solutions segment that do not fit into standard expense categories. These adjustments often involve legal settlements, restructuring charges, or unique accounting reclassifications. Monitoring this helps investors isolate core operating performance from one-time events.

Ask your AI about McKesson's medical-surgical solutions — other adjustments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude